Broadcom Stock Price Prediction: Where Will AVGO Be in 3 Years?

Broadcom reported Q1 FY2026 revenue of $19.31B (+29.5% YoY) and non‑GAAP EPS $2.05 (vs $2.02 est), with AI semiconductor revenue of $8.4B (+106% YoY), adjusted EBITDA margins of 68%, and free cash flow of $8.01B (+33.2% YoY). Management guided Q2 AI semiconductor revenue of $10.7B and total revenue ≈$22B (up ~47% YoY) and cited a $73B AI backlog, supporting upside toward analyst consensus targets (~$472) and a 24/7 Wall St. price target of $352.37 (9.26% upside; 90% model confidence). Key risks include hyperscaler customer concentration, heavy debt and a trailing P/E around 63x, dependence on TSMC wafer capacity (geopolitical/supply risk), and the bear-model 12‑month target of $283.65.

Analysis

Broadcom sits at an asymmetric information junction: the headline AI backlog ($73B) is real but the real value depends on conversion rhythm — ~ $73B/18 months implies roughly $4.0B of AI revenue recognized per month if conversion is linear, so the next 2–4 quarters of booking-to-revenue cadence are the decisive data points for valuation. Second-order winners include hyperscalers that secure preferential supply (GOOGL, AAPL) and packaging/ecosystem players that participate in board-level integration; losers are mid-tier ASIC designers that can be outcompeted on price/time-to-market as Broadcom vertically integrates more packaging and system IP.

Key catalysts are near-term (days–weeks) Q2 AI revenue and backlog disclosures, medium-term (quarters) hyperscaler capex cycles and any publicized booking cancellations, and structural (12–24 months) supply-chain shifts as Broadcom’s Singapore packaging and TSMC node dependence play out. Valuation sensitivity is acute — at ~63x trailing P/E a 5–10% EPS miss can mechanically compress the multiple 15–30% as expectations re-rate, so monitor sequential AI revenue growth and gross-margin differential between AI silicon and legacy software closely.

Practical implication: this is a trade around execution, not thesis. If Broadcom prints in-line or beats Q2 AI guidance, the stock should reprice toward the consensus $470s within 6–12 months; if bookings show cancellations or hyperscaler guidance weakens, downside to low-$280s is plausible within the same window. Volatility around the next earnings and any hyperscaler investor days offers structured-option entry points to capture upside while capping downside exposure.

Key Decisions for Investors

• Buy AVGO shares up to $325, target $472 in 12 months (≈+46%); size as 2–3% of portfolio and set a protective stop at $280 (≈-14%) — asymmetric R/R ~3.3:1 if guidance holds, hedge with short-dated puts if position >3% of portfolio.
• 1-year call spread (buy AVGO 12mo $330 call / sell $470 call) to express the beat-and-reprice scenario with defined max loss — ideal entry within 3 trading days after the Q2 print if AI revenue meets/exceeds guidance; expect 40–60% upside on premium if consensus re-rating occurs.
• Pair trade: long AVGO / short TSM equal notional for 3–9 months to isolate Broadcom execution vs foundry/geopolitics risk — take modest size (1–2% net exposure) and stop-loss if spread moves >20% against position, target 15–30% relative return.
• Protective hedge: buy AVGO 3-month 10% OTM puts around the next earnings release for existing long exposure (cost ~1–2% of position) to cap tail risk from a hyperscaler-guidance surprise that could compress 20–30% quickly.